Анализа корелације серумског ФГЛП1, УАЦР и ризика од срчане инсуфицијенције код пацијената са дијабетесом типа 2

Серум ФГЛП1, УАЦР и ризик од срчаног застоја код Т2Д

  • Lianheng Xia Одељење васкуларне хирургије, Прва афилирана болница Универзитета за традиционалну кинеску медицину Хеилунђијанга
  • Yingshuo Guo Одељење за кардиоваскуларну медицину, Централна болница Фушун
  • Jiaxin Wang Одељење васкуларне хирургије, Прва припојена болница Универзитета за традиционалну кинеску медицину Хеилунђијанга
  • Tingxuan Wang Одељење васкуларне хирургије, Прва припојена болница Универзитета за традиционалну кинеску медицину Хеилунђијанга
  • Chunhui Xu Одељења интерне медицине, Болница Оружане полиције Корпус Хеилунђијанг
  • Meiyu Song Одељење васкуларне хирургије, Прва приложна болница Универзитета за традиционалну кинеску медицину Хеилунђијанга
  • Chang Du Одељење ендокринологије, Прва афилирана болница Универзитета Ксиамен
  • Qingjie Wang Endocrinology Department, The First Affiliated Hospital of Xiamen University
  • Jie Gao Одељење васкуларне хирургије, Прва приложна болница Универзитета за традиционалну кинеску медицину Хеилунђијанга
DOI: https://doi.org/10.5937/jomb0-65295
Ključne reči: Дијабетес типа 2, Дијастолна дисфункција левог срчаног комора, Фибриноген-слични протеин 1 пептид са C-терминалом, Однос албумина у урину и креатинина

Sažetak


Objective To explore the correlations between serum FGLP1 (Fibrinogen-like protein 1 C-terminal peptide) levels, the urine albumin-to-creatinine ratio (UACR) and left ventricular diastolic dysfunction (LVDD) in elderly patients with type 2 diabetes mellitus (T2DM).

Methods From August 2023 to August 2025, 256 elderly patients with T2DM who were admitted to our hospital were selected as the case group, and 120 healthy individuals who underwent physical examinations were selected as the control group. In accordance with the diagnostic criteria for LVDD, T2DM patients were divided into a disorder group (n=70) and a nondisorder group (n=186), and single-factor analysis, multivariate logistic regression analysis, and Spearman correlation analysis were performed to explore the correlation between serum FGLP1 levels, UACRs and LVDD in T2DM patients, and receiver operating characteristic curves were used to evaluate the ability of serum FGLP1 levels and urine UACR to predict LVDD.

Results The serum FGLP1 concentration and urine UACR were higher in the case group than in the healthy group (P<0.05). There were statistically significant differences in age, disease duration, serum FGLP1 concentration and UACR between the LVDD group and the non-LVDD group (P<0.05). Multivariate logistic regression analysis revealed that age ≥ 75 years, long disease duration, elevated UACR, and elevated serum FGLP1 concentration were independent risk factors for LVDD in patients with T2DM (P<0.05). Spearman correlation analysis indicated a positive association between LVDD and serum FGLP1 levels as well as UACR (r = 0.551, 0.559; both P<0.05). The areas under the curve for predicting LVDD by serum FGLP1 concentration, urine UACR and the prediction model were 0.848, 0.896 and 0.956, respectively.

Conclusion Serum FGLP1 levels and urinary UACR in elderly patients with type 2 diabetes mellitus are closely related to LVDD. The combined detection of these two indicators is helpful for the early diagnosis of LVDD.

Reference

1.Gadó K, Tabák GÁ, Vingender I, Domján G, Dörnyei G. Treatment of type 2 diabetes mellitus in the elderly - Special considerations. Physiol Int. 2024 Apr 29;111(2):143-164. doi: 10.1556/2060.2024.00317. PMID: 38683666.
2.Hou Y, Xiang J, Wang B, Duan S, Song R, Zhou W, Tan S, He B. Pathogenesis and comprehensive treatment strategies of sarcopenia in elderly patients with type 2 diabetes mellitus. Front Endocrinol (Lausanne). 2024 Jan 8;14:1263650. doi: 10.3389/fendo.2023.1263650. PMID: 38260146; PMCID: PMC10801049.
3.Lu HH, Zhou Y, Chen C, Gu ZJ. Meta-analysis of the effect of exercise intervention on cognitive function in elderly patients with type 2 diabetes mellitus. BMC Geriatr. 2024 Sep 19;24(1):770. doi: 10.1186/s12877-024-05352-z. PMID: 39300333; PMCID: PMC11411744.
4.Sciacqua A, Succurro E, Armentaro G, Miceli S, Pastori D, Rengo G, Sesti G. Pharmacological treatment of type 2 diabetes in elderly patients with heart failure: randomized trials and beyond. Heart Fail Rev. 2023 May;28(3):667-681. doi: 10.1007/s10741-021-10182-x. Epub 2021 Dec 2. PMID: 34859336.
5.Chmieliauskaite M, Grosh MD, Syed A, Pinto A. An Elderly Patient with Undiagnosed Type 2 Diabetes Mellitus Presenting for an Emergency Extraction. Dent Clin North Am. 2023 Oct;67(4):609-611. doi: 10.1016/j.cden.2023.05.011. Epub 2023 Jul 3. PMID: 37714606.
6.Mansoori A, Nosrati M, Dorchin M, Mohammadyari F, Derakhshan-Nezhad E, Ferns G, Esmaily H, Ghayour-Mobarhan M. A novel index for diagnosis of type 2 diabetes mellitus: Cholesterol, High density lipoprotein, and Glucose (CHG) index. J Diabetes Investig. 2025 Feb;16(2):309-314. doi: 10.1111/jdi.14343. Epub 2024 Nov 21. PMID: 39569998; PMCID: PMC11786182.
7.Sun M, Chen WM, Wu SY, Zhang J. Metformin in elderly type 2 diabetes mellitus: dose-dependent dementia risk reduction. Brain. 2024 Apr 4;147(4):1474-1482. doi: 10.1093/brain/awad366. PMID: 37878862.
8.Bolt J, Carvalho V, Lin K, Lee SJ, Inglis C. Systematic review of guideline recommendations for older and frail adults with type 2 diabetes mellitus. Age Aging. 2024 Nov 1;53(11):afae259. doi: 10.1093/aging/afae259. PMID: 39572394; PMCID: PMC11581819.
9.Zhang RT, Liu Y, Sun C, Wu QY, Guo H, Wang GM, Lin KK, Wang J, Bai XY. Predicting hypoglycemia in elderly inpatients with type 2 diabetes: the ADOCHBIU model. Front Endocrinol (Lausanne). 2024 Nov 14;15:1366184. doi: 10.3389/fendo.2024.1366184. PMID: 39610841; PMCID: PMC11602273.
10.Liu Y, An C, Liu P, Yang F, Zhao Q. Comparative safety of sodium-glucose cotransporter 2 inhibitors in elderly patients with type 2 diabetes mellitus and diabetic kidney disease: a systematic review and meta-analysis. Ren Fail. 2023 Dec;45(1):2217287. doi: 10.1080/0886022X.2023.2217287. PMID: 37246403; PMCID: PMC10228313.
11.Liu Z, Sang X, Liu Y, Yu C, Wan H. Effect of psychological intervention on glycemic control in middle-aged and elderly patients with type 2 diabetes mellitus: A systematic review and meta-analysis. Prim Care Diabetes. 2024 Dec;18(6):574-581. doi: 10.1016/j.pcd.2024.09.006. Epub 2024 Sep 25. PMID: 39322480.
12.Grajower MM, LeRoith D. Management of Type 2 Diabetes Mellitus in the Very Elderly: One Practice's Experience. Endocr Pract. 2023 Jul;29(7):560-565. doi: 10.1016/j.eprac.2023.03.271. Epub 2023 Mar 24. PMID: 36965656.
13.Xie D, Shen Z, Yang L, Zhou D, Li C, Liu F. Global, regional, and national burden of type 2 diabetes mellitus attributable to particulate matter pollution from 1990 to 2021: An analysis of the global burden of disease study 2021. Diabetes Res Clin Pract. 2024 Dec;218:111934. doi: 10.1016/j.diabres.2024.111934. Epub 2024 Nov 16. PMID: 39557297.
14.Cheng J, Cheng Q, Wu Y, Yin J, He F. Association between triglyceride-glucose-body mass index and adverse prognosis in elderly patients with severe heart failure and type 2 diabetes: a retrospective study based on the MIMIC-IV database. Cardiovasc Diabetol. 2025 Jul 24;24(1):299. doi: 10.1186/s12933-025-02870-x. PMID: 40707996; PMCID: PMC12288297.
15.Wang Y, Wang J, Gong Q, Wu H, Yang S, He J, Hu X, Huang T. Efficacy and safety of glucagon-like peptide-1 receptor agonists in the elderly versus nonelderly patients with type 2 diabetes mellitus: insights from a systematic review. Endocr J. 2024 Jun 18;71(6):571-582. doi: 10.1507/endocrj.EJ23-0384. Epub 2024 Apr 20. PMID: 38644220.
16.Scheen AJ. Progress toward a personalized management of antidiabetic medications in the elderly with type 2 diabetes. Expert Rev Clin Pharmacol. 2025 Jun;18(6):373-383. doi: 10.1080/17512433.2025.2527092. Epub 2025 Jun 30. PMID: 40586635.
17.Yu QY, Chen YZ, Xu YX, Yu Q. Which intervention is optimal to control blood glucose and improve physical performance in the elderly living with type 2 diabetes mellitus? A network meta-analysis. Asia Pac J Clin Nutr. 2024 Sep;33(3):319-347. doi: 10.6133/apjcn.202409_33(3).0004. PMID: 38965721; PMCID: PMC11389812.
18.Sethi B, John M, Pendurthi B, Dharmadhikari S, Markandeywar N, Khandhedia C, Mane A, Mehta S. Exploring the Role of Sitagliptin in the Management of Type 2 Diabetes Mellitus for the Elderly: A Narrative Review. J Assoc Physicians India. 2025 Apr;73(4):e26-e32. doi: 10.59556/japi.73.0922. PMID: 40200620.
19.Weiss F, Brancati GE, Elefante C, Petrucci A, Gemmellaro T, Lattanzi L, Perugi G. Type 2 diabetes mellitus is associated with manic morbidity in elderly patients with mood disorders. Int Clin Psychopharmacol. 2024 Sep 1;39(5):294-304. doi: 10.1097/YIC.0000000000000515. Epub 2023 Oct 21. PMID: 37824397.
20.Wang MJ, Liu JL, Wang N, Han X, Zhang HX. The effectiveness and safety of linagliptin within elderly type 2 diabetes mellitus: a meta-analysis and systematic review. Minerva Endocrinol (Torino). 2024 Dec;49(4):427-435. doi: 10.23736/S2724-6507.22.03661-2. Epub 2022 Feb 1. PMID: 35103456.
21.Barman P, Das M, Verma M. Epidemiology of type 2 diabetes mellitus and treatment utilization patterns among the elderly from the first wave of Longitudinal Aging study in India (2017-18)using a Heckman selection model. BMC Public Health. 2023 Apr 14;23(1):699. doi: 10.1186/s12889-023-15661-4. PMID: 37059974; PMCID: PMC10103042.
22.Lin WQ, Liao YX, Wang JY, Luo LY, Yuan LX, Sun SY, Xu Y, Sun MY, Wang C, Zhou Q, Liu XY, Liu H. Associations between type 2 diabetes mellitus and risk of falls among community-dwelling elderly people in Guangzhou, China: a prospective cohort study. BMC Geriatr. 2024 Aug 29;24(1):717. doi: 10.1186/s12877-024-05314-5. PMID: 39210251; PMCID: PMC11363668.
23.Kaku K, Shimoda M, Osonoi T, Iwamoto M, Kaneto H. Efficacy and safety of imeglimin add-on to DPP-4 inhibitor therapy in Japanese patients with type 2 diabetes mellitus: An interim analysis of the randomized, double-blind FAMILIAR trial. Diabetes Obes Metab. 2025 Jun;27(6):3212-3222. doi: 10.1111/dom.16336. Epub 2025 Mar 21. PMID: 40116188; PMCID: PMC12046477.
24.Yan F, Peng G, Sun R, Zhang Y, Qiao P, Liu M, Ma Y, Han L. Identifying decision-making biases in self-care behaviors among patients with type 2 diabetes mellitus: A qualitative study from a behavioral economics perspective. Int J Nurs Stud. 2025 Nov;171:105182. doi: 10.1016/j.ijnurstu.2025.105182. Epub 2025 Aug 5. Erratum in: Int J Nurs Stud. 2025 Nov;171:105208. doi: 10.1016/j.ijnurstu.2025.105208. PMID: 40850026.
Objavljeno
2026/04/14
Broj časopisa
Ahead of print
Rubrika
Original paper

Sva prava zadržana (c) 2026 Lianheng Xia, Yingshuo Guo, Jiaxin Wang, Tingxuan Wang, Chunhui Xu, Meiyu Song, Chang Du, Qingjie Wang, Jie Gao

Creative Commons License

Ovaj rad je pod Creative Commons Autorstvo 4.0 međunarodnom licencom.

The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.